FOLH1 and prostate cancer: Afshar-Oromieh et al., in a retrospective analysis performed on 1007 patients who underwent Ga68- PSMA-11 PET/CT for recurrent prostate cancer, found that there is no significant difference in terms of Gleason scores between the patients with and without positive findings on scan [24].